These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 7318914)
1. Subcutaneous morphine reduces intestinal propulsion in rats partly by a central action. Burleigh DE; Galligan JJ; Burks TF Eur J Pharmacol; 1981 Nov; 75(4):283-7. PubMed ID: 7318914 [TBL] [Abstract][Full Text] [Related]
2. Antipropulsive effects of central and peripheral morphine in the rat gastrointestinal tract. Stewart JJ; Curd CD J Pharm Pharmacol; 1984 Jul; 36(7):476-7. PubMed ID: 6146697 [TBL] [Abstract][Full Text] [Related]
3. Morphine no longer blocks gastrointestinal transit but retains antinociceptive action in diallylnormorphine-pretreated rats. Tavani A; Bianchi G; Manara L Eur J Pharmacol; 1979 Oct; 59(1-2):151-4. PubMed ID: 510395 [TBL] [Abstract][Full Text] [Related]
4. Centrally mediated inhibition of small intestinal transit and motility by morphine in the rat. Galligan JJ; Burks TF J Pharmacol Exp Ther; 1983 Aug; 226(2):356-61. PubMed ID: 6875849 [TBL] [Abstract][Full Text] [Related]
5. Interactions of reserpine and morphine on rat intestinal transit. Stewart JJ J Pharmacol Exp Ther; 1981 Mar; 216(3):521-5. PubMed ID: 7205632 [TBL] [Abstract][Full Text] [Related]
6. Morphine tolerance and dependence in the rat intestine in vivo. Williams CL; Bihm CC; Rosenfeld GC; Burks TF J Pharmacol Exp Ther; 1997 Feb; 280(2):656-63. PubMed ID: 9023276 [TBL] [Abstract][Full Text] [Related]
7. Central and peripheral components of dermorphin's effect on rat intestinal propulsion in comparison to morphine. Parolaro D; Sala M; Crema G; Spazzi L; Cesana R; Gori E Peptides; 1983; 4(1):55-8. PubMed ID: 6866810 [TBL] [Abstract][Full Text] [Related]
8. Antidiarrheal and central nervous system activities of SC-27166 (2-[3 - 5 - methyl - 1, 3, 4 - oxadiazol - 2 - yl) - 3, 3 - diphenylpropyl] - 2 - azabicyclo [2.2.2]octane), a new antidiarrheal agent, resulting from binding to opiate receptor sites of brain and myenteric plexus. Mackerer CR; Brougham LR; East PF; Bloss JL; Dajani EZ; Clay GA J Pharmacol Exp Ther; 1977 Dec; 203(3):527-38. PubMed ID: 200732 [TBL] [Abstract][Full Text] [Related]
9. Effect of intracerebroventricular administration of morphine upon intestinal motility in rat and its antagonism with naloxone. Parolaro D; Sala M; Gori E Eur J Pharmacol; 1977 Dec; 46(4):329-38. PubMed ID: 590342 [TBL] [Abstract][Full Text] [Related]
10. Normalization of small intestinal propulsion with loperamide-like antidiarrheals in rats. Megens AA; Canters LL; Awouters FH; Niemegeers CJ Eur J Pharmacol; 1990 Mar; 178(3):357-64. PubMed ID: 2340864 [TBL] [Abstract][Full Text] [Related]
11. Centrally and peripherally mediated inhibition of intestinal motility by opioids. Schulz R; Wüster M; Herz A Naunyn Schmiedebergs Arch Pharmacol; 1979 Sep; 308(3):255-60. PubMed ID: 503253 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites. Manara L; Bianchi G; Ferretti P; Tavani A J Pharmacol Exp Ther; 1986 Jun; 237(3):945-9. PubMed ID: 3012075 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of gastric and intestinal motility by centrally and peripherally administered morphine. Galligan JJ; Burks TF Proc West Pharmacol Soc; 1982; 25():307-11. PubMed ID: 7122513 [No Abstract] [Full Text] [Related]
14. Morphine and the centrally-mediated inhibition of urinary bladder motility in the rat. Dray A; Metsch R Brain Res; 1984 Apr; 297(1):191-5. PubMed ID: 6722535 [TBL] [Abstract][Full Text] [Related]
15. Further investigations on neurotensin as central modulator of intestinal motility in rats. Parolaro D; Sala M; Patrini G; Biffi E; Pecora N; Gori E Regul Pept; 1987 Feb; 17(2):111-7. PubMed ID: 3107088 [TBL] [Abstract][Full Text] [Related]
16. Acute effects of morphine on rat intestinal motility. Burks TF Eur J Pharmacol; 1976 Dec; 40(2):279-83. PubMed ID: 991936 [TBL] [Abstract][Full Text] [Related]
17. Relative ability of N-methyl nalorphine and N-methyl levallorphan to prevent antinociception and intestinal transit inhibition in morphine treated rats. Notarnicola A; Landi M; Bianchi G; Tavani A Life Sci; 1983; 33 Suppl 1():481-4. PubMed ID: 6664229 [TBL] [Abstract][Full Text] [Related]
18. Pertussis toxin modifies the effect of central morphine on rat intestinal motility. Parolaro D; Patrini G; Massi P; Parenti M; Rubino T; Giagnoni G; Gori E Eur J Pharmacol; 1990 Feb; 177(1-2):75-80. PubMed ID: 2160368 [TBL] [Abstract][Full Text] [Related]
19. Effect of morphine sulfate on intestinal transit and myoelectric activity of the small intestine of the rat. Weisbrodt NW; Sussman SS; Stewart JJ; Burks TF J Pharmacol Exp Ther; 1980 Aug; 214(2):333-8. PubMed ID: 7391981 [TBL] [Abstract][Full Text] [Related]
20. Independent central and peripheral mediation of morphine-induced inhibition of gastrointestinal transit in rats. Gmerek DE; Cowan A; Woods JH J Pharmacol Exp Ther; 1986 Jan; 236(1):8-13. PubMed ID: 3941402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]